Health CanadaGeneral Alert
Infection-related deaths were reported with the use of MabCampath (alemtuzumab) ...
Published: November 21, 2008Recall ID: 24558Category: generalCountry: Canada
Product Description & Identification
Infection-related deaths were reported with the use of MabCampath (alemtuzumab) following initial combination therapy with anti-leukemia drugs which also suppress the body's immune response - Notice to Hospitals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24558 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/infection-related-deaths-were-reported-use-mabcampath-alemtuzumab-following-initial |
| Title | Infection-related deaths were reported with the use of MabCampath (alemtuzumab) following initial combination therapy with anti-leukemia drugs which also suppress the body's immune response - Notice to Hospitals |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2008-11-21 |
| Organization | Marketed health products |